vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
EDGEWELL PERSONAL CARE Co is the larger business by last-quarter revenue ($422.8M vs $339.0M, roughly 1.2× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 13.2% vs -15.5%, a 28.7% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (-2.7% vs -11.6%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $-137.5M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (0.4% CAGR vs -16.0%).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
EPC vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $339.0M |
| Net Profit | $-65.7M | $44.7M |
| Gross Margin | 38.1% | 59.7% |
| Operating Margin | -4.5% | 19.9% |
| Net Margin | -15.5% | 13.2% |
| Revenue YoY | -11.6% | -2.7% |
| Net Profit YoY | -3028.6% | 19.3% |
| EPS (diluted) | $-1.41 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | $339.0M | ||
| Q3 25 | $600.5M | $327.3M | ||
| Q2 25 | $627.2M | $321.4M | ||
| Q1 25 | $580.7M | $330.6M | ||
| Q4 24 | $415.1M | $348.5M | ||
| Q3 24 | $517.6M | $345.5M | ||
| Q2 24 | $647.8M | $336.2M | ||
| Q1 24 | $599.4M | — |
| Q4 25 | $-65.7M | $44.7M | ||
| Q3 25 | $-30.6M | $38.7M | ||
| Q2 25 | $29.1M | $34.0M | ||
| Q1 25 | $29.0M | $58.0M | ||
| Q4 24 | $-2.1M | $37.5M | ||
| Q3 24 | $8.8M | $33.8M | ||
| Q2 24 | $49.0M | $38.4M | ||
| Q1 24 | $36.0M | — |
| Q4 25 | 38.1% | 59.7% | ||
| Q3 25 | 37.9% | 59.5% | ||
| Q2 25 | 42.8% | 59.8% | ||
| Q1 25 | 44.1% | 58.4% | ||
| Q4 24 | 41.6% | 55.5% | ||
| Q3 24 | 41.1% | 54.2% | ||
| Q2 24 | 44.3% | 52.0% | ||
| Q1 24 | 43.1% | — |
| Q4 25 | -4.5% | 19.9% | ||
| Q3 25 | -4.2% | 17.9% | ||
| Q2 25 | 8.6% | 16.8% | ||
| Q1 25 | 10.1% | 21.6% | ||
| Q4 24 | 2.2% | 16.9% | ||
| Q3 24 | 3.9% | 15.0% | ||
| Q2 24 | 12.8% | 11.8% | ||
| Q1 24 | 11.7% | — |
| Q4 25 | -15.5% | 13.2% | ||
| Q3 25 | -5.1% | 11.8% | ||
| Q2 25 | 4.6% | 10.6% | ||
| Q1 25 | 5.0% | 17.5% | ||
| Q4 24 | -0.5% | 10.8% | ||
| Q3 24 | 1.7% | 9.8% | ||
| Q2 24 | 7.6% | 11.4% | ||
| Q1 24 | 6.0% | — |
| Q4 25 | $-1.41 | $0.95 | ||
| Q3 25 | $-0.65 | $0.81 | ||
| Q2 25 | $0.62 | $0.70 | ||
| Q1 25 | $0.60 | $1.17 | ||
| Q4 24 | $-0.04 | $0.74 | ||
| Q3 24 | $0.18 | $0.66 | ||
| Q2 24 | $0.98 | $0.74 | ||
| Q1 24 | $0.72 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $363.4M |
| Total DebtLower is stronger | $1.5B | $1.2B |
| Stockholders' EquityBook value | $1.5B | $911.5M |
| Total Assets | $3.8B | $2.5B |
| Debt / EquityLower = less leverage | 1.03× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $363.4M | ||
| Q3 25 | — | $296.4M | ||
| Q2 25 | — | $292.9M | ||
| Q1 25 | — | $306.8M | ||
| Q4 24 | — | $320.8M | ||
| Q3 24 | $209.1M | $299.3M | ||
| Q2 24 | — | $344.4M | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $1.5B | $911.5M | ||
| Q3 25 | $1.6B | $849.2M | ||
| Q2 25 | $1.6B | $882.3M | ||
| Q1 25 | $1.5B | $820.8M | ||
| Q4 24 | $1.5B | $906.9M | ||
| Q3 24 | $1.6B | $878.9M | ||
| Q2 24 | $1.6B | $905.4M | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $3.8B | $2.5B | ||
| Q3 25 | $3.8B | $2.4B | ||
| Q2 25 | $3.8B | $2.5B | ||
| Q1 25 | $3.8B | $2.5B | ||
| Q4 24 | $3.7B | $2.5B | ||
| Q3 24 | $3.7B | $2.5B | ||
| Q2 24 | $3.7B | $2.5B | ||
| Q1 24 | $3.8B | — |
| Q4 25 | 1.03× | 1.34× | ||
| Q3 25 | 0.89× | 1.44× | ||
| Q2 25 | 0.88× | 1.39× | ||
| Q1 25 | 0.95× | 1.49× | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | $93.6M |
| Free Cash FlowOCF − Capex | $-137.5M | $87.2M |
| FCF MarginFCF / Revenue | -32.5% | 25.7% |
| Capex IntensityCapex / Revenue | 2.7% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | $93.6M | ||
| Q3 25 | $74.1M | $111.3M | ||
| Q2 25 | $114.8M | $17.4M | ||
| Q1 25 | $45.1M | $116.6M | ||
| Q4 24 | $-115.6M | $43.8M | ||
| Q3 24 | $-388.3M | $48.8M | ||
| Q2 24 | $101.2M | $-27.4M | ||
| Q1 24 | $129.0M | — |
| Q4 25 | $-137.5M | $87.2M | ||
| Q3 25 | $46.5M | $106.3M | ||
| Q2 25 | $99.3M | $13.6M | ||
| Q1 25 | $28.0M | $100.9M | ||
| Q4 24 | $-132.4M | $35.2M | ||
| Q3 24 | $-414.2M | $39.4M | ||
| Q2 24 | $88.6M | $-33.1M | ||
| Q1 24 | $117.5M | — |
| Q4 25 | -32.5% | 25.7% | ||
| Q3 25 | 7.7% | 32.5% | ||
| Q2 25 | 15.8% | 4.2% | ||
| Q1 25 | 4.8% | 30.5% | ||
| Q4 24 | -31.9% | 10.1% | ||
| Q3 24 | -80.0% | 11.4% | ||
| Q2 24 | 13.7% | -9.8% | ||
| Q1 24 | 19.6% | — |
| Q4 25 | 2.7% | 1.9% | ||
| Q3 25 | 4.6% | 1.5% | ||
| Q2 25 | 2.5% | 1.2% | ||
| Q1 25 | 2.9% | 4.7% | ||
| Q4 24 | 4.0% | 2.5% | ||
| Q3 24 | 5.0% | 2.7% | ||
| Q2 24 | 1.9% | 1.7% | ||
| Q1 24 | 1.9% | — |
| Q4 25 | — | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | 3.95× | 0.51× | ||
| Q1 25 | 1.56× | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | -44.13× | 1.44× | ||
| Q2 24 | 2.07× | -0.71× | ||
| Q1 24 | 3.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
